Veralto acquired GlobalVision on March 31, 2026, integrating the inspection software company into its Esko business. The two companies had worked together for more than a decade before the deal closed, according to Esko’s announcement. That prior relationship matters: this was not a speculative bet on an unfamiliar technology. Veralto bought something it already understood.
Veralto states that GlobalVision’s technology uses AI-augmented inspection capabilities for text, graphics, and packaging compliance. Per Veralto’s announcement, GlobalVision’s tools are used by organizations in more than 100 countries. According to Veralto, the company is expected to generate approximately $25 million in revenue in 2026, with roughly 85% recurring. Veralto did not disclose the total acquisition price, but the company stated the deal values GlobalVision at approximately 15 times its estimated adjusted EBITDA of roughly $13 million, per the press release distributed via PR Newswire. Those financial terms could not be independently corroborated in financial reporting, the primary Veralto investor relations URL is currently unavailable.
Why does an established industrial technology company pay a reported ~15x EBITDA multiple for a packaging inspection software firm? Because the customers it serves, consumer packaged goods companies and pharmaceutical manufacturers, face mounting pressure on regulatory compliance and brand consistency. “Consumer packaged goods and pharmaceutical companies are facing incredible demands to meet regulatory and brand consistency standards,” according to Veralto. AI-augmented inspection tools that automate text and graphics verification directly address those demands. The recurring revenue profile (roughly 85% per Veralto’s projection) is precisely the kind of business model industrial acquirers pay a premium to own. It is predictable. It is sticky. It scales without linear headcount growth.
The broader signal is the category, not the company. For years, AI quality control tools occupied a narrow lane: promising to developers, invisible to corporate strategy teams. That is changing. When a company like Veralto, a public industrial technology firm with a focused portfolio, structures an acquisition around AI-augmented inspection, it means quality control AI has cleared the bar for enterprise M&A. The technology is mature enough to carry a valuation multiple. The customer base is large enough to justify integration investment. The recurring revenue model is defined enough to underwrite the deal. This is what enterprise AI adoption looks like in sectors that don’t make headlines: deliberate, quiet, and structurally significant.
Watch for two downstream effects. First, Esko’s integration timeline will signal how quickly Veralto expects GlobalVision’s AI capabilities to reach its existing customer base, and whether Veralto treats the technology as a product addition or a platform transformation. Second, expect comparable acquisitions in adjacent regulated industries. Medical device labeling, chemical compliance, and food safety documentation all share the same underlying demand: automated verification that keeps pace with regulatory velocity. GlobalVision’s deal sets a comparable for that category.
For enterprise technology strategists and investors tracking AI adoption in industrial markets, the TJS read is this: AI quality control has crossed from “interesting pilot” to “M&A asset class” in regulated manufacturing and packaging. Veralto’s move is an early data point. It will not be the last acquisition in this space.